# Assessing the Functional Significance of Novel and Rare Variants of the SLC26A4 Gene Found in Patients with Hearing Loss by Minigene Assay

**Authors:** Valeriia Yu. Danilchenko, Ekaterina A. Panina, Marina V. Zytzar, Konstantin E. Orishchenko, Olga L. Posukh

PMC · DOI: 10.3390/ijms262110732 · 2025-11-04

## TL;DR

This study assesses the impact of rare SLC26A4 gene variants on hearing loss by testing their effect on splicing in Siberian patients.

## Contribution

The study experimentally validates the functional impact of novel and rare SLC26A4 variants using a minigene assay.

## Key findings

- c.2034+1G>A caused aberrant splicing in vitro.
- c.1708-18T>A led to exon 16 skipping in a small proportion of transcripts.
- Most tested variants showed no detectable splicing effect.

## Abstract

The SLC26A4 gene is one of the key genes involved in the etiology of hearing loss. It encodes pendrin, a transmembrane transporter protein functioning as a multifunctional anion exchanger. About 600 pathogenic SLC26A4 variants are known to cause either nonsyndromic recessive hearing loss (DFNB4) or Pendred syndrome (hearing loss and thyroid dysfunction). While most pathogenic variants occur in coding regions and disrupt pendrin structure or function, about 25% are thought to impair splicing. For many, pathogenicity has been assessed only in silico, with limited experimental confirmation. We identified several novel and rare SLC26A4 variants in patients with hearing loss from the Tyva and Altai Republics (Southern Siberia, Russia). Based on splicing predictions, six variants—intronic c.2034+1G>A, c.1545-168A>G, c.1708-125T>C, c.1708-18T>A, c.1804-31C>T, and exonic c.942A>G—were selected for analysis using a minigene assay. The results of in vitro analysis only partially matched in silico predictions: c.2034+1G>A caused aberrant splicing; c.1708-18T>A led to exon 16 skipping only in a small proportion of transcripts; the remaining variants showed no detectable splicing effect. These findings underscore the need for integrating in silico predictions with in vitro validation to accurately assess the functional impact of genetic variants, enabling their correct interpretation and reliable molecular diagnosis.

## Linked entities

- **Genes:** SLC26A4 (solute carrier family 26 member 4) [NCBI Gene 5172]
- **Proteins:** Slc26a4 (solute carrier family 26, member 4)
- **Diseases:** hearing loss (MONDO:0005365), Pendred syndrome (MONDO:0010134)

## Full-text entities

- **Genes:** SLC26A4 (solute carrier family 26 member 4) [NCBI Gene 5172] {aka DFNB4, EVA, PDS, TDH2B}
- **Diseases:** DFNB4 (OMIM:600791), Hearing Loss (MESH:D034381), nonsyndromic recessive hearing loss (MESH:C580334), Pendred syndrome (MESH:C536648), thyroid dysfunction (MESH:D013959)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.2034+1G>A, c.942A>G, c.1545-168A>G, c.1708-125T>C, c.1708-18T>A, c.1804-31C>T

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12610559/full.md

---
Source: https://tomesphere.com/paper/PMC12610559